Literature DB >> 22926360

Evaluation of the relationship between heart type fatty acid binding protein levels and the risk of maternal cardiac ischemia in low risk obstetric population during delivery.

Nermin Akdemir1, Suleyman Akarsu, Sevgi Türe, Veciha Ozlem Akcinar, Ahmet Arif Yalcin, Cemil Bilir, Arif Serhan Cevrioglu, Selcuk Ozden, Murat Yucel, Yusuf Yurumez.   

Abstract

AIM: To investigate the heart type fatty acid binding protein (hFABP) changes during delivery in low-risk obstetric population.
METHODS: Pregnant women who are at term and met the inclusion criteria were included the study. Maternal echocardiography, electrocardiography, arterial blood pressure monitoring, CK-MB, serum heart type fatty acid binding protein and troponin I levels were evaluated before and after delivery. Of the total of 100 pregnant women, mean age was 26.7±5, 51 pregnant had vaginal delivery and the remaining 49 had caesarean section.
RESULTS: The h-FABP positivity was detected in nine (9%) subjects after the delivery as compared to values before the delivery (p=0.0035). Troponin levels were 0.013±0.001 before the delivery and 0.025±0.002 after the delivery (p= 0.0001). In the comparison of vaginal and Cesarean deliveries, h-FABP positivity was detected in five of 51 subjects in the vaginal delivery group and four of 49 subjects in the cesarean delivery group (p=0.95). The changes in troponin levels were 0.01 ng/mL (-0.02 to 0.2) in the vaginal delivery group and 0.01ng/mL (-0.07 to 0.06) in the cesarean delivery group (p= 0.24).
CONCLUSION: Delivery stress is associated with maternal cardiac damage as evaluated by heart type fatty acid binding protein and troponin. There was no difference between the two delivery routes in the risk of maternal cardiac damage.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22926360

Source DB:  PubMed          Journal:  Med Glas (Zenica)        ISSN: 1840-0132


  1 in total

Review 1.  Catecholaminergic Ventricular Tachycardia, Pregnancy and Teenager: Are They Compatible?

Authors:  Katie P Friday; Jeffrey P Moak; Melissa H Fries; Sara N Iqbal
Journal:  Pediatr Cardiol       Date:  2015-08-18       Impact factor: 1.655

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.